Amphastar Pharmaceuticals, Inc. (AMPH)
Makes generic injectable drugs for emergencies, allergies, and chronic conditions.
$20.15+0.05%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-5.0%
The outlook
AMPH is trading near the lower end of its 52-week range, with analysts holding a neutral stance overall. The average price target sits about 9% above the current price, though the stock is showing mixed momentum against its moving averages. A low trailing P/E of 12.1 suggests limited valuation premium relative to earnings.
What’s behind the score
Analyst consensusHold — 3.1 avg of 6 analysts
Price trendMixed vs its moving averages
52-week range24% of the way from its 52-week low to high
Price targetAvg target +9% vs current price
Analyst price target
~12-month · 6 analysts$22.00average target+9.2% vs now
Now $20.15
Low $19.00High $30.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$888.5M
52-wk high
$31.26
52-wk low
$16.65
50-day avg
$19.25
200-day avg
$23.04
Trailing P/E
12.1